Profile: Otsuka America Pharmaceutical, Inc. (OAPI) is a healthcare company. We focus on neuroscience, cardiovascular and gastrointestinal therapeutic treatments. Our products are marketed under the brand name Pletal® (cilostazol), Abilify®(aripiprazole) and Zegerid®(omeprazole) powder for oral suspension. Our Abilify is a treatment option for biplolar, disorder, schizophrenia, and depressive disorder.
FDA Registration Number: 3000718406
4 Products/Services (Click for related suppliers)
|
• Breath/Blood Urea Test (FDA Code: MSQ / 866.3110) |
• Cardiovascular Equipment Kits |
• Cardiovascular Systems |
• Cardiovasculars |